News

News
Partner news

Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease

Read full story
Partner news

GI Windows Raises $16.4M in Series A-1 Financing

Read full story
Partner news

Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases

Read full story
Partner news

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

Read full story
Partner news

Thirty Madison Raises $47M in Series B Financing From Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc. and Existing Investors

Read full story
Partner news

ViaCyte and Gore Enter Clinical Phase Agreement Based on Novel Membrane Technology for PEC-Encap Product Candidate

Read full story
Partner news

Accelerator Life Science Partners Launches Magnolia Neurosciences Corporation with $31 Million Series A to Develop Targeted Neuroprotective Therapies

Read full story
Partner news

CVRx® Secures $113 Million in New Financing

Read full story
Partner news

Torax Medical, Inc. Raises $25 Million in Series E Funding and Welcomes New Chief Commercial Officer

Read full story
Partner news

Merus Enters into 72.8 million Euro Series C Financing

Read full story
Partner news

Catalyst Biosciences Completes Merger with Targacept and Creates a Protease-Based Hemostasis and Anti-Complement Company

Read full story
Partner news

Johnson & Johnson Innovation Announces Collaboration on Immuno-Oncology Antibody ADC-1013 with Alligator Bioscience

Read full story
Partner news

Aquinox Pharmaceuticals Commences Phase II Clinical Trial of AQX-1125 in Bladder Pain Syndrome/Interstitial Cystitis

Read full story
Partner news

Celladon Corporation Announces First Patient Dosed in CUPID Phase 2b Trial of MYDICAR® for Advanced Heart Failure

Read full story
Partner news

Allergan and Molecular Partners Enter into Exclusive Alliance

Read full story